iroGates on positive EMA opinion of suPAR-guided Kineret treatment - Jakob Knudsen , CEO, ViroGates 00:00:00

Share On Facebook Share On Twitter

CEO Jakob Knudsen of ViroGates about yesterday's press release regarding the CHMP, advisory board to the EMA, having adopted a positive opinion of Kineret (anakinra) for suPAR-guided treatment of adult patients with COVID-19 pneumonia.

Recent Videos